ARGATROBAN INJECTION

Texas Biotechnology Corporation

Application Filed: 2000-11-08

Trademark Application Details

Mark For: ARGATROBAN INJECTION™ trademark registration is intended to cover the categories of pharmaceutical product for use as an anticoagulant and for the treatment of heparin-induced thrombocytopenia with or without thrombosis, acute coronary syndromes, ischemic stroke, percutaneous coronary interventions, venous thrombosis, arterial thrombosis, coagulopathies, pulmonary embolism, peripheral embolism and hemodialysis. [all]

Status

2022-02-18 UTC

DEAD APPLICATION Refused Dismissed or Invalidated

This trademark application was refused, dismissed, or invalidated by the Office and this application is no longer active.

Research	OneLook Acronym Finder
Serial Number	76161856
Mark Literal Elements	ARGATROBAN INJECTION
Mark Drawing Type	3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S)
Mark Type	TRADEMARK
Standard Character Claim	No
Register	PRINCIPAL
Current Location	FILE REPOSITORY (FRANCONIA) 2004-01-29
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Martin L. Katz
Law Office Assigned	M60
Employee Name	EDWARDS, ALICIA COLLIN

Timeline

2000-11-08	Application Filed
2000-11-30	Date of First Use
2000-11-30	Date of Use In Commerce
2002-07-02	Published
2002-07-02	Published for Opposition
2003-12-08	Abandon
2004-01-24	Status: Abandoned because the applicant failed to respond or filed a late response to an Office action. To view all documents in this fi
2004-01-24	Status: Dead/Abandoned
2004-01-29	Location: FILE REPOSITORY (FRANCONIA)
2018-07-08	Transaction Date

Trademark Parties (Applicants & Owners)

Party:	Texas Biotechnology Corporation
Address	7000 Fannin Houston, TEXAS UNITED STATES 77030
Legal Entity Type	Corporation
Legal Entity State	DELAWARE

Documents

Application	IMAGE/TIFF	2000-11-08
Drawing	IMAGE/TIFF	2000-11-08
Paper Correspondence Incoming		2003-03-25
Offc Action Outgoing		2003-05-29
Paper Correspondence Incoming		2003-06-17
Paper Correspondence Incoming		2003-07-02
Notice of Abandonment		2004-01-26

Design Search Codes

26.05.02	Plain single line triangles; Triangles, plain single line
26.17.13	Letters or words underlined and/or overlined by one or more strokes or lines; Overlined words or letters; Underlined words or letters
260121	Circles that are totally or partially shaded.
260502	Plain single line triangles; Triangles, plain single line
261713	Letters or words underlined and/or overlined by one or more strokes or lines; Overlined words or letters; Underlined words or letters

Attorney of Record

MARTIN L. KATZ
WOOD, PHILLIPS, KATZ, CLARK & MORTIMER
CITICORP CENTER, SUITE 3800
500 WEST MADISON STREET
CHICAGO IL 60661-2511

Good, Services, and Codes

(ABANDONED)
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical product for use as an anticoagulant and for the treatment of heparin-induced thrombocytopenia with or without thrombosis, acute coronary syndromes, ischemic stroke, percutaneous coronary interventions, venous thrombosis, arterial thrombosis, coagulopathies, pulmonary embolism, peripheral embolism and hemodialysis. FIRST USE: 20001130. FIRST USE IN COMMERCE: 20001130

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
D10000	"INJECTION"

Trademark Filing History

Description	Date	Proceeding Number
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE	2004-01-24
UNRESPONSIVE/DUPLICATE PAPER RECEIVED	2003-07-02
PAPER RECEIVED	2003-07-02
PAPER RECEIVED	2003-06-17
NON-FINAL ACTION MAILED	2003-06-05
STATEMENT OF USE PROCESSING COMPLETE	2003-05-23
PAPER RECEIVED	2003-03-25
USE AMENDMENT FILED	2003-03-24
NOA MAILED - SOU REQUIRED FROM APPLICANT	2002-09-24
PUBLISHED FOR OPPOSITION	2002-07-02
NOTICE OF PUBLICATION	2002-06-12
APPROVED FOR PUB - PRINCIPAL REGISTER	2002-01-23
CORRESPONDENCE RECEIVED IN LAW OFFICE	2001-09-28
NON-FINAL ACTION MAILED	2001-03-29
ASSIGNED TO EXAMINER	2001-03-21	74819

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.